Wedbush Maintains Neutral on DocuSign, Raises Price Target to $65
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Daniel Ives maintains a Neutral rating on DocuSign (DOCU) and raises the price target from $56 to $65.

March 08, 2024 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Daniel Ives maintains a Neutral rating on DocuSign and raises the price target from $56 to $65.
The increase in price target from $56 to $65 by Wedbush reflects a positive outlook on DocuSign's valuation, potentially leading to increased investor confidence and a short-term positive impact on the stock price. However, the maintenance of a Neutral rating suggests that while the outlook is improved, there may still be factors that could limit significant upside in the near term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100